Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
- PMID: 22002595
- DOI: 10.1007/s11060-011-0714-2
Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights
Abstract
With advances in genomic profiling and sequencing technology, we are beginning to understand the landscape of the genetic events that accumulated during the neoplastic process. The insights gleamed from these genomic profiling studies with regards to glioblastoma etiology has been particularly satisfying because it cemented the clinical pertinence of major concepts in cancer biology-concepts developed over the past three decades. This article will review how the glioblastoma genomic data set serves as an illustrative platform for the concepts put forward by Hanahan and Weinberg on the cancer phenotype. The picture emerging suggests that most glioblastomas evolve along a multitude of pathways rather than a single defined pathway. In this context, the article will further provide a discussion of the subtypes of glioblastoma as they relate to key principles of developmental neurobiology.
Similar articles
-
Emerging insights into the molecular and cellular basis of glioblastoma.Genes Dev. 2012 Apr 15;26(8):756-84. doi: 10.1101/gad.187922.112. Genes Dev. 2012. PMID: 22508724 Free PMC article. Review.
-
Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.Cancer Res. 2006 Dec 1;66(23):11502-13. doi: 10.1158/0008-5472.CAN-06-2072. Epub 2006 Nov 17. Cancer Res. 2006. PMID: 17114236
-
Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.Genes Chromosomes Cancer. 2009 Jan;48(1):55-68. doi: 10.1002/gcc.20618. Genes Chromosomes Cancer. 2009. PMID: 18828157
-
Identifying causal genes and dysregulated pathways in complex diseases.PLoS Comput Biol. 2011 Mar;7(3):e1001095. doi: 10.1371/journal.pcbi.1001095. Epub 2011 Mar 3. PLoS Comput Biol. 2011. PMID: 21390271 Free PMC article.
-
Molecular Pathogenesis and Emerging Treatment for Glioblastoma.World Neurosurg. 2018 Aug;116:495-504. doi: 10.1016/j.wneu.2018.04.021. World Neurosurg. 2018. PMID: 30049044 Review.
Cited by
-
Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis.Oncotarget. 2016 May 3;7(18):24899-907. doi: 10.18632/oncotarget.8551. Oncotarget. 2016. PMID: 27056901 Free PMC article.
-
Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid.Cancer Biomark. 2016 Mar 25;17(2):125-32. doi: 10.3233/CBM-160609. Cancer Biomark. 2016. PMID: 27062568 Free PMC article.
-
20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.Cancer Sci. 2019 Jan;110(1):389-400. doi: 10.1111/cas.13881. Epub 2018 Dec 14. Cancer Sci. 2019. PMID: 30431207 Free PMC article.
-
Epigenetic suppression of EGFR signaling in G-CIMP+ glioblastomas.Oncotarget. 2014 Sep 15;5(17):7342-56. doi: 10.18632/oncotarget.2350. Oncotarget. 2014. PMID: 25277177 Free PMC article.
-
Orthogonal targeting of EGFRvIII expressing glioblastomas through simultaneous EGFR and PLK1 inhibition.Oncotarget. 2015 May 20;6(14):11751-67. doi: 10.18632/oncotarget.3996. Oncotarget. 2015. PMID: 26059434 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous